Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
pharmorubicin or pirarubicin
Start Date
September 1, 2015
Primary Completion Date
December 1, 2020
Last Updated
September 11, 2015
NCT06668493
NCT07225374
NCT07126119
Lead Sponsor
Xuesong Li
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions